Rhenman & Partners Asset Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Rhenman & Partners Asset Management’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$3.35M	Sell
2025 Q1	$3.32M	Hold
2024 Q4	$3.05M	Sell
2024 Q3	$4.09M	Sell
2024 Q2	$4.59M	Buy
2024 Q1	$2.32M	Buy